CRNX

Crinetics Pharmaceuticals

• PUBT·05/22 20:05

  Crinetics Pharmaceuticals joins Jefferies Global Healthcare Conference, schedules investor meetings

• TipRanks·05/20 06:55

  Crinetics Pharma Bets Big on Palsonify Launch

• Simply Wall St·05/16 06:38

  Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Q1 2026 Revenue Growth And Wider Net Loss

• TipRanks·05/15 21:28

  3 Best Healthcare Stocks to Buy in May 2026, According to Analysts

• Dow Jones·05/15 17:42

  Crinetics Pharmaceuticals Price Target Cut to $88.00/Share From $89.00 by Evercore ISI Group

• Dow Jones·05/15 17:42

  Crinetics Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

• Benzinga·05/15 17:31

  Evercore ISI Group Maintains Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $88

• Simply Wall St·05/13 12:03

  Industry Analysts Just Upgraded Their Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Revenue Forecasts By 11%

• TipRanks·05/11 17:08

  Crinetics price target lowered to $84 from $87 at Oppenheimer

• Benzinga·05/11 16:25

  Twilio To Rally Over 25%? Here Are 10 Top Analyst Forecasts For Monday

• Dow Jones·05/11 16:05

  Crinetics Pharmaceuticals Is Maintained at Outperform by Oppenheimer

• Dow Jones·05/11 16:05

  Crinetics Pharmaceuticals Price Target Cut to $84.00/Share From $87.00 by Oppenheimer

• Benzinga·05/11 15:56

  Oppenheimer Maintains Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $84

• Reuters·05/11 12:21

  CRINETICS PHARMACEUTICALS <CRNX.O>: OPPENHEIMER CUTS TARGET PRICE TO $84 FROM $87

• Reuters·05/11 07:27

  U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla